Enterovirus Infections clinical trials
The registry lists 48 studies for Enterovirus Infections across more than 10 countries. 3 are recruiting or about to start. 22 of them are mainly about Enterovirus Infections (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-11. Counting its 4 narrower conditions too, such as Poliomyelitis: 470 studies, 39 open.
Get an email when these change. Save the Enterovirus Infections studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Gilead Sciences (7) · Enimmune Corporation (5) · Sinovac Biotech Co., Ltd (4) · University Hospital, Clermont-Ferrand (2) · Romark Laboratories L.C. (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Oslo University Hospital (2) · National Taiwan University Hospital (1)
What is being tested here
Drugs under test in Enterovirus Infections studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Enterovirus 71 vaccine | 0 | 1 | 6 |
| EV71 | 0 | 0 | 3 |
| Pleconaril | 0 | 0 | 2 |
| Nitazoxanide | 0 | 2 | 2 |
| Sofosbuvir | 0 | 1 | 2 |
| Vapendavir | 0 | 0 | 1 |
| Oral Polio Vaccine | 0 | 0 | 1 |
| Ribavirin | 0 | 0 | 1 |
| Voxilaprevir | 0 | 0 | 1 |
| Polyethylene Glycols | 0 | 0 | 1 |
Who these studies take
Of the 3 Enterovirus Infections studies recruiting now, 0 (0%) set no upper age limit and 3 (100%) stop at 75 or younger. 3 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 2 (67%) | 2 (67%) |
| 18 | 1 (33%) | 1 (33%) |
| 30 | 1 (33%) | 1 (33%) |
| 40 | 1 (33%) | 1 (33%) |
| 50 | 1 (33%) | 1 (33%) |
| 65 | 1 (33%) | 1 (33%) |
| 75 | 1 (33%) | 1 (33%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 48 studies, recruiting or not: 71% stop at 75 or younger and 65% at 65; 60% take children; 2% are for women only and 0% for men only; 33% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 48 of 48. search them.
- Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on Echovirus 11RecruitingNCT073565831 country
- Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health PerspectiveRecruitingNCT073589101 country
- Surveillance of HFMD in Pediatric OutpatientsRecruitingNCT062634391 country
- A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and ChildrenCompletedNCT05099029Phase 32 countries
- Extension Study of Protocol EV-BR1701 Group B1CompletedNCT076304931 country
- An Extension Study of EV-BR1701 Part A1CompletedNCT076359661 country
- Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy AdultsCompletedNCT06444048Phase 11 country
- Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory VirusesActive, not recruitingNCT05864118Not applicable1 country
- Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and DiabetesCompletedNCT04769167Not applicable1 country
- RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory InfectionCompletedNCT06149494Phase 21 country
- Molecular Epidemiology of Enteroviruses Detected at the Virology Laboratory of Brest University Hospital During the Period 2018-2024: Retrospective Analysis of an Atypical Meningitis Epidemic in 2024 (BrEcho9Men)Active, not recruitingNCT069224741 country
- Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory PathogensTerminatedNCT044310501 country
- Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus InfectionTerminatedNCT04489381Phase 31 country
- Live Enterovirus Vaccine and Type 1 DiabetesCompletedNCT02961595Phase 1
- LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in AustraliaStatus unknownNCT06392451Not applicable1 country
- Pleconaril Enteroviral Sepsis SyndromeCompletedNCT00031512Phase 22 countries
- Detection of Enterovirus Genotypes by CRISPR TechnologyWithdrawnNCT04535648
- Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza VaccineCompletedNCT04091880Phase 41 country
- Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus InfectionCompletedNCT03605862Phase 32 countries
- First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers.CompletedNCT05016687Phase 11 country
- A Study to Evaluate the Immunogenicity and Safety of EV71 Vaccine in Pediatric SubjectsCompletedNCT03268083Phase 21 country
- Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in InfantsWithdrawnNCT01812135Phase 21 country
- Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy ChildrenCompletedNCT01273246Phase 11 country
- The Diabetes Virus Detection and Intervention TrialCompletedNCT04838145Phase 21 country
- Characterization of Cytokines Expression During Enterovirus Meningitis in Paediatric Populations.Status unknownNCT047118761 country
- Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus InfectionCompletedNCT02185794Phase 12 countries
- Enterovirus Surveillance During the Perinatal PeriodStatus unknownNCT043851341 country
- Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV InfectionCompletedNCT01768286Phase 31 country
- Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)CompletedNCT01851330Phase 31 country
- Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCVCompletedNCT01701401Phase 37 countries
- Diabetes Virus Detection Project, Intervention With GAD-alumTerminatedNCT01129232Phase 21 country
- Gene-virus Interactions Implicated in Type 1 DiabetesWithdrawnNCT02804165Not applicable1 country
- A New Enzymatic Assay for Rapid Diagnosing of Central Nervous System Enteroviral InfectionWithdrawnNCT008649031 country
- A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine in Pediatric Subjects Aged 3 to 6 Years and 6 to 35 Months OldCompletedNCT02777411Phase 21 country
- Neurodevelopment Outcomes Following Severe Hand Foot and Mouth Disease in VietnamCompletedNCT020667141 country
- Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) InfectionCompletedNCT01838590Phase 31 country
- Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71CompletedNCT01376479Phase 11 country
- A Study to Evaluate the Safety and Immunogenicity of EV71 VaccineCompletedNCT01268787Phase 11 country
- Detection of Enterovirus RNA in Atheromatous LesionsCompletedNCT00674531Not applicable1 country
- Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3CompletedNCT01808248Phase 21 country
- Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis CApproved for marketingNCT01779518
- Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy AdultsCompletedNCT01273233Phase 11 country
- Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled StudyCompletedNCT01769794Not applicable1 country
- Safety and Immunogenicity of an Inactivated EV71 Vaccine in InfantsCompletedNCT01421121Phase 21 country
- A Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and InfantsCompletedNCT01313715Phase 11 country
- Urinary Excretion of Enteroviruses From Children With a Presumed Enteroviral InfectionCompletedNCT004266991 country
- Betaferon/ Betaseron (Interferon Beta-1b) in Patients With Chronic Viral CardiomyopathyCompletedNCT00185250Phase 27 countries
- Environmental Enterovirus MonitoringStatus unknownNCT001731211 country